# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hemophagocytic Lymphohistiocytosis (HLH)

Hemophagocytic lymphohistiocytosis
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 49 results.
Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH)
Status: Recruiting
Last Changed: Aug 13, 2019
First Received: Aug 23, 2017
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Blood Draws, Data Collection
Locations: University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis
Status: Terminated
Last Changed: Jul 20, 2018
First Received: Mar 07, 2012
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): IST and/or alloHCT
Locations: Asan Medical center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)
Status: Recruiting
Last Changed: Feb 07, 2019
First Received: Dec 10, 2013
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): tocilizumab
Locations: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis
Status: Completed
Last Changed: Nov 16, 2016
First Received: Apr 15, 2010
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): ATG, rabbit, Etoposide, Methotrexate, hydrocortisone, Dexamethasone
Locations: Phoenix Children's Hospital, Phoenix, Arizona, United States
University of California, San Francisco Department of Pediatrics, San Francisco, California, United States
Stanford University, Stanford, California, United States
University of Colorado, Aurora, Colorado, United States
Nemours, Wilmington, Delaware, United States
... and 11 other locations.
Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)
Status: Recruiting
Last Changed: Sep 13, 2018
First Received: Apr 27, 2018
Disease(s): Hemophagocytic Lymphohistiocytosis
Locations: Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany
Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004
Status: Completed
Last Changed: Jul 04, 2018
First Received: Jan 24, 2007
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Dexamethasone, Etoposide, Cyclosporin, Intrathecal therapy, Stem cell transplant
Locations: Childhood Cancer Research Unit, Karolinska Hospital, Stockholm, Sweden
L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis
Status: Recruiting
Last Changed: Aug 04, 2016
First Received: Dec 16, 2015
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Pegaspargase, doxorubicin, etoposide, methylprednisolone
Locations: Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
L-DEP as an Initial Treatment for EBV-HLH
Status: Unknown status
Last Changed: Sep 23, 2016
First Received: Sep 23, 2016
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Pegaspargase, doxorubicin hydrochloride liposome injection, etoposide, methylprednisolone, Etoposide, dexamethasone
Locations: Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
Status: Not yet recruiting
Last Changed: Jun 13, 2019
First Received: Jun 13, 2019
Disease(s): Hemophagocytic Lymphohistiocytoses
Intervention(s): Emapalumab-Lzsg
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
MD Anderson Cancer Center, Houston, Texas, United States
Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.
Status: Recruiting
Last Changed: Sep 05, 2019
First Received: Sep 04, 2019
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Pegylated liposomal doxorubicin, Etoposide, Methylprednisolone
Locations: Beijing Friendship Hospital, Beijing, China